ReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2024 Earnings Call Transcript
Michael Miller: Good afternoon, everyone, and thank you for joining the third quarter 2024 ReShape Lifesciences' earnings call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | D E Shaw D. E. Shaw | 0 | $0 | -100% | 0% |
2. | 0 | $0 | -100% | 0% | |
3. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.00 | 0 | Large Shareholder | 5,330,277 | 2020-12-04 | Filing | |
$4.13 | 5,400 | Large Shareholder | 5,330,277 | 2020-12-04 | Filing | |
$0.00 | 0 | Large Shareholder | 5,324,877 | 2020-12-02 | Filing | |
$4.31 | 1,000 | Large Shareholder | 5,324,877 | 2020-12-02 | Filing | |
$0.00 | 0 | Large Shareholder | 5,323,877 | 2020-11-17 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.00 | 20,487 | Director | 26,200 | 2017-12-19 | Filing | |
$4.85 | 97 | Director | 0 | 2017-05-25 | Filing | |
$4.85 | 4,571 | Director | 0 | 2017-05-25 | Filing | |
$4.85 | 97 | Director | 0 | 2017-05-25 | Filing | |
$4.85 | 4,571 | Director | 0 | 2017-05-25 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 12.781,724,137,931 | $21,000 | 0% |